Sign in Subscribe
BioMed

🧬 BioMed Pulse · 2026-06-17 02:02 UTC

BIOMED PULSE

Tuesday, June 17, 2026 — Daily Briefing on Longevity, Viruses & New Cures

⚡ TL;DR

The Bundibugyo virus Ebola outbreak in DRC and Uganda has surpassed 676 confirmed cases and 136 deaths as of June 10, remaining the world's most urgent active PHEIC — and it is still accelerating. Mood: grimly watchful on two fronts as food-safety Listeria alerts and a new Salmonella warning compound a crowded outbreak landscape.

---

🦠 OUTBREAKS & VIRUSES

EBOLA BUNDIBUGYO VIRUS — DRC AND UGANDA (ACTIVE PHEIC)

  • As of June 10, 2026, the DRC has reported 676 confirmed cases and 136 deaths from Bundibugyo virus disease (BVD), with cross-border transmission continuing into Uganda. [1]
  • WHO declared this outbreak a Public Health Emergency of International Concern on May 17, 2026; the IHR Emergency Committee confirmed it does not yet meet the threshold for pandemic emergency. [2] [3]
  • Africa CDC and WHO jointly launched a continental preparedness and response plan on June 5, 2026, seeking to raise US$518 million to support African countries in containment. [4]
  • WHO expert groups have assessed candidate treatments and vaccines specific to Bundibugyo virus, but no approved countermeasure for this strain yet exists. [5]
  • CDC has mobilized international response teams and expanded enhanced Ebola airport screening from Washington-Dulles to Atlanta as of May 23, 2026. [6] [7]
  • The outbreak was first alerted to WHO on May 5, 2026, after high-mortality illness among health workers in Mongbwalu Health Zone, Ituri Province, DRC. [8]

HANTAVIRUS — M/V HONDIUS CRUISE SHIP (MULTI-COUNTRY, ONGOING)

  • The Andes hantavirus cluster linked to the M/V Hondius cruise ship has resulted in confirmed and suspected cases among passengers from 23 countries, with at least 3 deaths among the initial 8 reported cases. [9] [10]
  • WHO's fourth Disease Outbreak News report (published May 28, 2026) confirmed additional cases since the May 13 update; the Andes hantavirus strain was identified as the causative pathogen. [10]
  • CDC confirmed ongoing monitoring and stated public risk to Americans remains extremely low; over 120 passengers were safely disembarked in Tenerife, Spain with WHO coordination. [11] [12]

SALMONELLA — PISTACHIO CREAM (NEW ALERT, JUNE 16, 2026)

  • CDC warns of a new Salmonella outbreak linked to pistachio cream; 4 people have been sickened with the same Salmonella strain as of the June 16 alert. [13]
  • This adds to an already crowded Salmonella surveillance picture that includes active outbreaks linked to backyard poultry (13 states, 34 cases as of April 23) and moringa leaf products (growing number of illnesses across multiple states). [14] [15]

LISTERIA — CHICKEN FETTUCCINE ALFREDO MEALS

  • CDC reports 17 people sickened by the same Listeria strain linked to recalled chicken fettuccine alfredo meals; a recall is in effect and consumers are urged to discard affected products. [16]
  • A separate active Listeria outbreak linked to requesón/soft ricotta cheese was also flagged by CDC on June 5, 2026. [17]

MPOX CLADE IB — GLOBAL SPREAD

  • WHO's December 2025 Disease Outbreak News flagged local clade Ib MPXV transmission among men who have sex with men in countries not previously affected, beyond the African epicenter. [18]
  • A recombinant MPXV strain combining clade Ib and IIb genomic elements was documented in two cases globally as of February 2026, raising concern about novel viral evolution. [19]

MEASLES — BANGLADESH AND GLOBAL

  • Bangladesh reported 19,161 suspected measles cases and 2,897 laboratory-confirmed cases across 58 of 64 districts as of the April 2026 WHO Disease Outbreak News report. [20]
  • WHO and CDC previously documented 10.3 million measles cases globally in 2023, signaling a sustained reversal of prior vaccination gains. [21]

MERS-COV — GLOBAL UPDATE

  • Since the start of 2025 and through December 21, 2025, WHO recorded 19 MERS-CoV cases including 4 deaths: 17 from Saudi Arabia, 2 from France. [22]

NEW WORLD SCREWWORM

  • CDC activated its Emergency Operations Center for a New World Screwworm response on June 12, 2026, marking an unusual parasitic threat requiring coordinated federal mobilization. [23]

---

🧬 LONGEVITY & AGING

CELLULAR SENESCENCE AND KIDNEY REPAIR

  • A new Europe PMC study (Mao et al., Renal Failure, June 14, 2026) finds that AMD1-mediated polyamine metabolism governs whether injured kidney tubular cells repair themselves or enter permanent senescence — identifying AMD1 as a potential therapeutic target to preserve organ function with age. [24]

DNA METHYLATION, TELOMERE LENGTH, AND BRAIN ANEURYSM RISK

  • Zhang et al. (IBRO Neuroscience Reports, May 30, 2026) used genetic (Mendelian randomization) methods to show DNA methylation-estimated biological age phenotypes and shorter telomere length are associated with elevated risk of intracranial aneurysms, linking epigenetic aging clocks to cerebrovascular vulnerability. [25]

INTRINSIC CAPACITY AND DISABILITY BEFORE DEATH

  • Malkowski, Davis-Plourde, Western, and Gill (Lancet Healthy Longevity) followed a decedent cohort of older adults and found that higher intrinsic capacity — a composite of cognitive, locomotor, sensory, vitality, and psychological domains — was associated with compressed disability in the period before death. [26]
  • A linked editorial by Hanewald in the same issue frames intrinsic capacity and disability as a dynamic, modifiable relationship rather than a fixed trajectory, reinforcing case for early intervention. [27]

HANDGRIP STRENGTH AND DIGESTIVE DISEASE RISK

  • Liu et al. (Global Health Action, June 15, 2026) conducted a prospective parallel analysis in Chinese and European older adults, finding that lower combined handgrip strength predicted incident chronic digestive diseases across both populations — supporting grip strength as a practical biomarker of systemic aging. [28]

ANTI-OSTEOPOROSIS DRUGS AND FRACTURE HEALING

  • A systematic review and meta-analysis published in Lancet Healthy Longevity (Agarwal, Bell, Ross, Clement, Ralston, Duckworth) finds anti-osteoporotic medications do not impair fracture healing and may improve outcomes — directly countering longstanding clinical hesitancy about continuing these drugs post-fracture. [29]
  • An accompanying editorial by Paccou argues clinicians should treat the underlying bone disease rather than withhold medication out of fear during healing. [30]

MATERNAL DIET, NEONATAL MICROBIOME, AND NEUROMETABOLIC RESILIENCE

  • Kadyan et al. (Gut Microbes, June 9, 2026) demonstrate in a preclinical model that maternal diet shapes neonatal gut microbiome composition and developmental trajectory, with downstream effects on neurometabolic resilience — a finding relevant to programming of long-term health from birth. [31]

AMYLOID PET IMAGING IN THE BALTIMORE LONGITUDINAL STUDY OF AGING

  • A ClinicalTrials.gov-registered study (NCT07099053) is using PET imaging to track amyloid protein accumulation longitudinally in aging participants enrolled in the Baltimore Longitudinal Study of Aging, aiming to clarify which individuals face elevated Alzheimer's risk before symptoms appear. [32]

PHYSICAL ACTIVITY AND COGNITION IN OLDER ADULTS WITH ALZHEIMER'S

  • An ongoing clinical trial (NCT03866018) is evaluating whether structured physical activity can preserve self-esteem and motivation in adults over 60 with minor-to-major cognitive disorders including Alzheimer's disease and related dementias. [33]

URIC ACID, FERROPTOSIS, AND PARKINSON'S DISEASE

  • Zhou et al. (Redox Reports, June 4, 2026) show that uric acid reduces neuroinflammation and protects dopaminergic neurons in both LPS-induced cell cultures and an MPTP mouse model of Parkinson's disease, acting through the Nrf2 signaling pathway to resist ferroptosis — a regulated form of oxidative cell death increasingly implicated in neurodegeneration. [34]

---

💊 NEW CURES & APPROVALS

WELIREG (BELZUTIFAN) — MERCK SHARP DOHME

  • Merck Sharp Dohme received a supplemental approval (SUPPL AP) for Welireg (belzutifan), a HIF-2 alpha inhibitor, expanding its oncology indications via NDA215383; belzutifan was originally approved for VHL disease-associated tumors. [35]

KEYTRUDA (PEMBROLIZUMAB) — MERCK SHARP DOHME

  • Merck Sharp Dohme received a supplemental approval for Keytruda (pembrolizumab, BLA125514), the PD-1 checkpoint inhibitor; a subcutaneous co-formulation, Keytruda QLEX (pembrolizumab plus berahyaluronidase alfa-pmph, BLA761467), also received a supplemental action — offering a potential under-the-skin delivery alternative to IV infusion. [36] [37]

TRUQAP (CAPIVASERTIB) — ASTRAZENECA

  • AstraZeneca's Truqap (capivasertib, NDA218197), an AKT kinase inhibitor used in HR-positive/HER2-negative advanced breast cancer, received a supplemental approval action. [38]

YERVOY (IPILIMUMAB) — BRISTOL MYERS SQUIBB

  • Bristol Myers Squibb received a supplemental approval for Yervoy (ipilimumab, BLA125377), the CTLA-4 checkpoint inhibitor with established indications in melanoma, lung cancer, and other solid tumors. [39]

RINVOQ LQ (UPADACITINIB) — ABBVIE

  • AbbVie's Rinvoq LQ (upadacitinib liquid formulation, NDA218347), a JAK1 selective inhibitor, received a supplemental approval — the liquid form broadens administration options, likely for pediatric or dysphagic patients. [40]

TZIELD (TEPLIZUMAB-MZWV) — PROVENTION BIO

  • Provention Bio's Tzield (teplizumab-mzwv, BLA761183), a CD3-directed antibody that delays Stage 3 Type 1 diabetes onset in at-risk individuals, received a supplemental approval action. [41]

EMPAGLIFLOZIN/METFORMIN HCL — AUROBINDO PHARMA LIMITED

  • Aurobindo Pharma received an original tentative approval (ORIG TA) for a generic empagliflozin/metformin hydrochloride combination tablet (ANDA212374), broadening future access to this SGLT2-inhibitor/biguanide combination used in Type 2 diabetes. [42]

---

🧪 CLINICAL TRIALS

PATHWAY-RCT: ATTR CARDIOMYOPATHY HOSPITAL PREVENTION

  • The PATHWAY-RCT (NCT05098665, updated June 16, 2026) is evaluating strategies to prevent hospital admissions in transthyretin (ATTR) cardiac amyloidosis — a disease of aging where misfolded transthyretin protein stiffens the heart muscle, disproportionately affecting older adults. [43]

AMYLOID PET IN THE BALTIMORE LONGITUDINAL STUDY OF AGING

  • NCT07099053 is actively enrolling participants to track brain amyloid accumulation via PET scan in the long-running Baltimore Longitudinal Study of Aging cohort, seeking early imaging biomarkers for Alzheimer's risk stratification. [32]

TIRZEPATIDE IN METABOLIC ALCOHOL-ASSOCIATED LIVER DISEASE (METALD)

  • NCT07046819 is testing tirzepatide, the approved GIP/GLP-1 receptor dual agonist, in people with alcohol use disorder who have developed metabolic alcohol-associated liver disease (MetALD) — a potentially fatal combination of hepatic and metabolic dysfunction. [44]

IPATH FOR CARE PARTNER DEPRESSION IN DEMENTIA

  • NCT07631247 (iPath for CP Pilot, updated June 16, 2026) is piloting a depression treatment program specifically for care partners of people living with dementia, a population rarely screened or treated despite high depression burden. [45]

PHYSICAL ACTIVITY FOR COGNITION AND SELF-ESTEEM IN ALZHEIMER'S

  • NCT03866018 is studying the contribution of structured physical activity to self-esteem and motivation in adults over 60 with cognitive disorders ranging from mild impairment to diagnosed Alzheimer's disease or related dementias. [33]

---

📢 PUBLIC HEALTH

INFANT BOTULISM — NARA ORGANICS FORMULA RECALL

  • CDC issued an outbreak update on June 13, 2026 urging parents to immediately stop using all Nara Organics Whole Milk Organic Infant Formula, linked to confirmed infant botulism cases. [46]

ACIP MEETING SCHEDULED FOR JUNE 25-26, 2026

  • CDC's Advisory Committee on Immunization Practices will convene June 25-26, 2026; agenda items were not yet specified but the meeting follows recent policy shifts including individualized decision-making frameworks for COVID-19 and hepatitis B vaccines. [47]

WHO ON UNSAFE FOOD — 866 MILLION ILLNESSES ANNUALLY

  • WHO released new estimates on June 3-4, 2026 showing unsafe food causes 866 million illnesses and 1.5 million deaths per year globally; children under 5 face nearly three times the illness risk of older individuals. [48]

WHO GLOBAL HEALTH STATISTICS 2026 — PROGRESS REVERSING

  • WHO's World Health Statistics 2026 report (published May 13, 2026) warns that global health targets are being missed, with progress uneven, slowing, and in some areas reversing — compounded by the U.S. completing its formal WHO withdrawal on January 22, 2026. [49] [50]

TICK BITE ER VISITS ELEVATED

  • CDC data show weekly emergency room visits for tick bites are running higher than usual for the season as of April 23, 2026; CDC urges use of repellents and prompt tick checks. [51]

---

This briefing is informational only and does not constitute medical advice. Always consult a qualified health professional for personal health decisions.

📎 Sources

  1. Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda — WHO Disease Outbreak News
  2. Epidemic of Ebola Disease caused by Bundibugyo virus in the Democratic Republic of the Congo and Uganda determined a pub — WHO News
  3. First meeting of the IHR Emergency Committee regarding the epidemic of Ebola Bundibugyo virus disease in the Democratic — WHO News
  4. Africa CDC and WHO launch joint continental Ebola response plan — WHO News
  5. Experts convened by WHO advise on candidate treatments and vaccines for Ebola disease caused by Bundibugyo virus — WHO News
  6. Enhanced Ebola Airport Screening Begins at Washington-Dulles International Airport — CDC Newsroom
  7. Enhanced Ebola Airport Screening Expands to Atlanta — CDC Newsroom
  8. Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda — WHO Disease Outbreak News
  9. WHO’s response to hantavirus cases linked to a cruise ship — WHO News
  10. Hantavirus outbreak linked to cruise ship travel, Multi-locations — WHO Disease Outbreak News
  11. CDC Provides Update on Hantavirus Outbreak Linked to M/V Hondius Cruise Ship — CDC Newsroom
  12. Follow-up message by the WHO Director-General to the people of Tenerife regarding the hantavirus response — WHO News
  13. CDC warns of <em>Salmonella</em> outbreak linked to pistachio cream — CDC Newsroom
  14. CDC announces <em>Salmonella</em> outbreak in 13 states linked to backyard poultry. — CDC Newsroom
  15. Alert Update: Growing number of Salmonella illnesses and outbreaks linked to moringa leaf products — CDC Newsroom
  16. CDC warns of <em>Listeria</em> outbreak linked to recalled chicken fettuccine alfredo meals — CDC Newsroom
  17. CDC warns of Listeria outbreak linked to requesón/soft ricotta cheese — CDC Newsroom
  18. Broader transmission of mpox due to clade Ib MPXV – Global situation — WHO Disease Outbreak News
  19. Mpox: recombinant virus with genomic elements of clades Ib and IIb – Global situation — WHO Disease Outbreak News
  20. Measles - Bangladesh — WHO Disease Outbreak News
  21. Measles cases surge worldwide, infecting 10.3 million people in 2023 — CDC Newsroom
  22. Middle East respiratory syndrome coronavirus - Global update — WHO Disease Outbreak News
  23. CDC Activates Emergency Operations Center for New World Screwworm Response — CDC Newsroom
  24. AMD1-mediated polyamine metabolism governs tubular repair fate by restraining senescence after kidney injury. — Europe PMC — Longevity
  25. DNA methylation-estimated phenotypes, telomere length, aging and risk of intracranial aneurysms: Evidence from genetic s — Europe PMC — Longevity
  26. Association between intrinsic capacity and disability before death among older adults: a decedent cohort study. — Europe PMC — Longevity
  27. Intrinsic capacity and disability before death: a dynamic relationship. — Europe PMC — Longevity
  28. Combined handgrip strength and incident chronic digestive diseases: a prospective parallel analysis examining broad and — Europe PMC — Longevity
  29. The effects of anti-osteoporotic medication on fracture healing and outcomes: a systematic review and meta-analysis. — Europe PMC — Longevity
  30. Treat the bone, not the fear: antiosteoporosis medications and fracture healing. — Europe PMC — Longevity
  31. Maternal diet shapes neonatal microbiome ontogenesis and neurometabolic resilience. — Europe PMC — Longevity
  32. Amyloid PET Imaging in the Baltimore Longitudinal Study of Aging — ClinicalTrials.gov — Aging
  33. Contribution of Physical Activity to Self-esteem and Motivation in Older Adults With Minor to Major Cognitive Disorders — ClinicalTrials.gov — Aging
  34. Uric acid alleviates the inflammatory response in LPS-induced BV2 cells and MPTP-induced PD mice by resisting ferroptosi — Europe PMC — Longevity
  35. WELIREG — MERCK SHARP DOHME — openFDA — Drugs@FDA
  36. KEYTRUDA — MERCK SHARP DOHME — openFDA — Drugs@FDA
  37. KEYTRUDA QLEX — MERCK SHARP DOHME — openFDA — Drugs@FDA
  38. TRUQAP — ASTRAZENECA — openFDA — Drugs@FDA
  39. YERVOY — BRISTOL MYERS SQUIBB — openFDA — Drugs@FDA
  40. RINVOQ LQ — ABBVIE — openFDA — Drugs@FDA
  41. TZIELD — PROVENTION BIO INC — openFDA — Drugs@FDA
  42. EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE — AUROBINDO PHARMA LIMITED — openFDA — Drugs@FDA
  43. PATHWAY-RCT: Preventing Admission To Hospital With Attr cardiomyopathY — ClinicalTrials.gov — Aging
  44. Tirzepatide in MetALD — ClinicalTrials.gov — Aging
  45. iPath for CP Pilot — ClinicalTrials.gov — Aging
  46. CDC Outbreak Update: Infant Botulism Linked to Powdered Infant Formula — CDC Newsroom
  47. CDC's Advisory Committee on Immunization Practices to Meet June 25-26 — CDC Newsroom
  48. Unsafe food causes 866 million illnesses and 1.5 million deaths annually, young children at highest risk — WHO News
  49. Global health gains face threat of reversal — WHO News
  50. United States Completes WHO Withdrawal — CDC Newsroom
  51. CDC Data Show Weekly ER Visits for Tick Bites Higher than Usual — CDC Newsroom

Curated from official sources — WHO/CDC/ECDC/openFDA/ClinicalTrials.gov/Europe PMC. Informational only — not medical advice.
Serial 20260617-02-v3 · 2026-06-17 02:02 UTC

Read next